Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Switch from Kivexa to Truvada in HIV-1 adults with elevated cholesterol
2008-002043-16Phase 4Completed
- Sponsor
- Gilead Sciences
- Start
- Jul 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in Human immunodeficiency virus infection type 1 comparing Switch to Truvada + Kaletra with Continue Kivexa + Kaletra (2 arms). Primary endpoint: Change from baseline in total cholesterol at Week 12. Started Jul 2008; status: completed.
02
Drugs
emtricitabine + tenofovir disoproxilabacavir + lamivudinelopinavir + ritonavir
03
Conditions
Human immunodeficiency virus infection type 1
Beyond the preview
Go deeper on 2008-002043-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-002043-16.